Rohan Khazanchi, M.D., M.P.H., is an internist-pediatrician and health services researcher. He is a resident physician in the Harvard Internal Medicine-Pediatrics ("Med-Peds") Combined Residency Program at Brigham & Women's Hospital, Boston Children's Hospital, and Boston Medical Center. He is also a research affiliate at the FXB Center for Health and Human Rights at Harvard University. At BMC, he received grant funding from the Joel and Barbara Alpert Endowment for Children of the City and the BMC Center for the Urban Child and Healthy Family to evaluate BMC's 2021 policy which ended automatic Child Protective Services reporting for prenatal substance exposure (https://www.bmc.org/news/new-study-shows-promising-results-boston-medical-centers-revised-clinical-guidelines-mandatory). He is also a co-leader of the Department of Pediatrics' Health Equity Rounds conference series (https://www.bmc.org/health-equity-rounds).

Rohan's clinical and extraclinical work strives to advance health equity for and with marginalized populations, with particular interest in redressing the (mis)use of race in clinical algorithms and improving the health of children, young adults, and families who have interfaced with carceral systems. His work has been published in leading journals including NEJM, Health Affairs, JAMA Pediatrics, Pediatrics, and JGIM; has been cited in federal regulations and used to directly inform state legislation; and has been covered widely in news outlets including the New York Times, Washington Post, Boston Globe, STAT, and Kaiser Family Foundation.

Rohan's prior public service experience includes work with two state Medicaid programs on re-entry coverage for incarcerated youth & adults. He advised the NYC Health Department’s Coalition to End Racism in Clinical Algorithms as lead author of CERCA’s inaugural report and is currently a health services research consultant to the New York Academy of Medicine assisting with the design and deployment of program evaluations at two CERCA health systems. He has been invited to NASEM twice to testify on organizational and regulatory interventions to redress the harms of race-based clinical algorithms. He is an appointed commissioner on The Lancet’s Commission on Antiracism in Solidarity and a strategic advisory council member for the Rise to Health Coalition, two national initiatives seeking to embed equity across the public health and healthcare ecosystems. As a voting delegate in the AMA House of Delegates (2018-present) and member of the AMA Council on Medical Education (2020-22), he has led the writing and adoption of foundational AMA policies on structural racism as a public health threat, racial essentialism in medicine, redressing the Flexner Report’s impact on workforce diversity, repairing the health and economic harms of race-based medicine, and ending the Medicaid Inmate Exclusion Policy.